Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,700.4
88.8 (3.40%)

 

  • STI Straits Times Index
    2,700.4
    88.8 (3.40%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,538.5
    30.8 (2.05%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,325.6
    329.7 (1.37%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,923.4
    2.0 (0.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,613.8
    288.1 (1.29%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,941.0
    93.5 (1.93%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,748.2M
  • Value: 2,480.4M
  • Rise: 237
  • Fall: 143
  • Unch: 428

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.192-0.003
ComfortDelGro1.610+0.120
Singtel2.570+0.030
Mapletree Log Tr1.950-0.060
ThaiBev0.715+0.035
ESR-REIT0.395-0.020
CapitaMall Trust2.140+0.010
Golden Agri-Res0.160+0.006
Secura0.093-0.007
AusGroup0.029+0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,608.4 +56.3
HSI 24,325.6 +329.7
HSCEI 9,967.5 +91.3
Jakarta 4,941.0 +93.5
Nikkei 225 22,613.8 +288.1
SSE Comp 2,923.4 +2.0
Shanghai A 3,064.3 +2.1
Shanghai B 205.3 -2.4
KOSPI 2,147.0 +59.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AIM IMMUNOTECH INC AIM IMMUNOTECH
Updated on 02 Jun 2020 (End of trading day)
Last (USD): 2.690 Change: -0.090 High: 2.730 Remarks: -
Change (%): -3.24 Low: 2.550
Open 2.690 Yesterday's Close 2.78
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,936,459 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.32662 Trailing EPS (USD) e -0.34170 NAV (USD) b 1.1766
PE a - Trailing PE f - Price / NAV b 2.2862
Dividend (USD) d - Cash In Hand (USD) g 0.9453 Issued & Paid-up Shares c 29,186,500
Dividend Yield (%) d - Price / Cash In Hand g 2.846 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 78.512
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 57.798
Piotroski F Score 1 Exchange Code AIM Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 93.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AIM IMMUNOTECH INC NYSE American 78.512 - - 2.2862 -
Industry Biotechnology NYSE American 118.740 - - 3.5411 -
Local Peer NANOVIRICIDES INC NYSE American 481.239 - - 62.3366 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 297.124 - - 336.6667 -
Local Peer PFENEX INC NYSE American 175.526 165.888 - 2.1103 -
Local Peer IBIO INC NYSE American 152.223 - - 38.4075 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 136.337 - - 1.2802 -
Local Peer CEL-SCI CORP NYSE American 134.625 - - 11.0270 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 82.692 - - 1.1229 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 85.309 2.385 2.300 0.9841 -
Local Peer 22ND CENTURY GROUP INC NYSE American 81.499 - - 1.3978 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 69.918 - - 2.0882 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 50.119 - - -9.6020 -
Local Peer ORAGENICS INC NYSE American 27.377 - - 4.7732 -
Other Local Peers INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 131,602.619 16.782 17.147 13.8748 2.606
Global Peer GILEAD SCIENCES INC NASDAQ 91,868.040 17.057 18.514 4.1631 3.473
Global Peer CSL ASX 128,745.594 47.987 44.444 14.8866 0.935
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer VERTEX PHARMACEUTICAL NASDAQ 73,704.673 62.631 48.781 11.4065 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 69,500.320 32.848 30.492 5.7282 -
Global Peer ILLUMINA INC NASDAQ 53,809.350 53.702 57.122 11.6094 -
Global Peer BIOGEN INC NASDAQ 49,422.815 8.393 8.407 3.9390 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,879.475 26.031 40.935 5.8472 0.727
Global Peer SEATTLE GENETICS INC NASDAQ 27,838.264 - - 15.7668 -
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), MODERNA INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE (HKEx), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), GENSCRIPT BIO (HKEx), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), PTC THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), ALECTOR INC (NASDAQ), INSMED INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), ALPHAMAB-B (HKEx), TG THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), XENCOR INC (NASDAQ), EPIZYME INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIVA BIOTECH (HKEx), LUMINEX CORP(DEL) (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), CORTEXYME INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), COMPUGEN (NASDAQ), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), NANOSTRING TECHNOLOGIES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FRONTAGE (HKEx), INTELLIA THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEXTCURE INC (NASDAQ), OMEROS CORP (NASDAQ), ASCENTAGE-B (HKEx), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), NANTKWEST INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), REPLIMUNE GROUP INC (NASDAQ), AGENUS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AVITA MEDICAL LTD (ASX), RETROPHIN INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), ARDELYX INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), ATHERSYS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ANAPTYSBIO INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UROGEN PHARMA LTD (NASDAQ), SINOMAB BIO-B (HKEx), GERON CORP (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VBI VACCINES INC CDA (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), ASCLETIS-B (HKEx), PUMA BIOTECHNOLOGY INC (NASDAQ), PERSONALIS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), VERMILLION INC (NASDAQ), MERUS B V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ESSEX BIO-TECH (HKEx), WAVE LIFE SCIENCES LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), KAMADA (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), LEE'S PHARM (HKEx), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), ADURO BIOTECH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), BBI LIFE SCI (HKEx), EVOFEM BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), AFFIMED N V (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), INFLARX N V (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), XOMA CORP (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VAXART INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), IVERIC BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ENZO BIOCHEM INC (NYSE), TREVENA INC (NASDAQ), CONTRAFECT CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), SAVARA INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), GLYCOMIMETICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), UNI-BIO GROUP (HKEx), CHAMPIONS ONCOLOGY INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IMUGENE LIMITED (ASX), T2 BIOSYSTEMS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), SESEN BIO INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), IMMUTEP LTD (ASX), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), INMUNE BIO INC (NASDAQ), VACCINEX INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ANIXA BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), BIOTRON (ASX), ADVAXIS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOSINO BIO-TEC (HKEx), CURIS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), BIONANO GENOMICS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIOCARDIA INC (NASDAQ), TOCAGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), EVOGENE LTD (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), ANTEOTECH LIMITED (ASX), ALIMERA SCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), CLEVELAND BIOLABS INC (NASDAQ), Suntar Eco-City (SGX), BIO-PATH HOLDINGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIONOMICS LTD (ASX), UNUM THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), SENECA BIOPHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), REGENT PACIFIC (HKEx), REGENEUS LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), RHINOMED LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), ADALTA LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), HAO WEN HLDGS (HKEx), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), LEAF RESOURCES LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.350
+14.96 %
10 Days -+0.270
+11.16 %
20 Days -+0.710
+35.86 %
Medium Term Return 3 Months -+0.310
+13.03 %
6 Months -+2.249
+509.98 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.381 - 7.110 Change From 1 Year Low +2.309 % Change From 1 Year Low (%) +606.04
Change From 1 Year High -4.420 % Change From 1 Year High (%) -62.17
2 Years Range 0.381 - 7.110 Change From 2 Years Low +2.309 % Change From 2 Years Low (%) +606.04
Change From 2 Years High -4.420 % Change From 2 Years High (%) -62.17
5 Years Range 0.381 - 7.110 Change From 5 Years Low +2.309 % Change From 5 Years Low (%) +606.04
Change From 5 Years High -4.420 % Change From 5 Years High (%) -62.17
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Jun 2020 2.690 2.730 2.550 2.690 2,936,459 -
01 Jun 2020 2.870 2.890 2.590 2.780 4,283,780 -
29 May 2020 2.770 2.850 2.470 2.800 10,759,080 -
28 May 2020 2.290 2.500 2.250 2.500 4,283,345 -
27 May 2020 2.340 2.380 2.220 2.340 2,007,891 -
26 May 2020 2.430 2.430 2.300 2.400 1,968,266 -
22 May 2020 2.390 2.450 2.310 2.370 1,380,629 -
21 May 2020 2.390 2.406 2.280 2.360 1,634,657 -
20 May 2020 2.500 2.510 2.380 2.420 1,510,137 -
19 May 2020 2.530 2.540 2.420 2.460 1,515,570 -
18 May 2020 2.480 2.850 2.210 2.570 4,296,042 -
15 May 2020 2.680 2.770 2.500 2.560 5,013,962 -
14 May 2020 3.230 3.450 2.700 2.940 36,822,630 -
13 May 2020 2.490 2.680 2.160 2.350 6,696,414 -
12 May 2020 2.350 2.550 2.240 2.400 5,068,214 -
11 May 2020 2.150 2.340 2.090 2.300 3,017,029 -
08 May 2020 2.110 2.220 2.060 2.150 1,890,944 -
07 May 2020 2.000 2.070 1.950 2.070 1,254,644 -
06 May 2020 2.020 2.050 1.960 1.980 959,674 -
05 May 2020 2.150 2.150 1.960 2.020 1,545,067 -
04 May 2020 1.960 2.150 1.950 2.130 1,697,554 -
01 May 2020 2.040 2.050 1.980 2.020 1,073,790 -
Summary
Current 2 Weeks
(19 May 2020 to 02 Jun 2020)
2.530 2.890 2.220 2.690 32,279,814 -
Previous 2 Weeks
(05 May 2020 to 18 May 2020)
2.150 2.890 1.960 2.570 66,564,620 -
4 Weeks from
(06 Apr 2020 to 04 May 2020)
2.870 2.950 2.220 2.130 49,975,368 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.